Evidence and controversies on impact of HPV infection on OPC
Sunday, October 8, 2017
•
HN 04
•
1:45 PM
>
3:30 PM
•
Evidence and controversies on impact of HPV infection on OPC
•
G 105
•
HN 04-01
•
Influence of HPV on transformation Pro
>
A.
Amanda
PSYRRI
•
HN 04-02
•
Influence of HPV on transformation Con
See abstract
>
C.
Carolin
GÖTZ
•
HN 04-03
•
Detection of HPV, a criterion for therapeutic decision? Pro
>
J.
Jean
LACAU ST. GUILY
•
HN 04-04
•
Detection of HPV, a criterion for therapeutic decision? Con
>
A.
Andreas
KOLK
•
HN 04-05
•
Use of oral HPV infection or blood bio-markers for early identification of recurrence Pro
>
H.
Haïtham
MIRGHANI
•
HN 04-06
•
Use of oral HPV infection or blood bio-markers for early identification of recurrence Con
>
M.
Magnus
VON KNEBEL DOEBERITZ
•
HN 04-07
•
Microbiote associated with oral cancer, a diagnostic-prognostic marker?
See abstract
>
J.
Jaana
RAUTAVA
•
HN 04-08
•
The value of p16ink4a as a surrogate marker
>
R.
Ruud
BRAKENHOFF
•
HN 04-09
•
The role of serological markers
See abstract
>
T.
Tim
WATERBOER
•
INT1
•
Conclusion: validation and standardization perspective
|